Related Experiment Video
Updated: Jun 26, 2025
12:29
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
10.3K
Formulary Drug Review: Rezafungin
Brittney Kessel1, Danial E Baker1
1Washington State University, Spokane, WA, USA.
Hospital Pharmacy
|May 20, 2024
Summary
The Formulary Monograph Service provides monthly drug monographs and utilization evaluations for Pharmacy & Therapeutics Committees. This service aids in informed drug decision-making and medication use evaluation for healthcare facilities.
Area of Science:
- Pharmaceutical Sciences
- Health Services Research
Background:
- Pharmacy & Therapeutics (P&T) Committees require timely, evidence-based drug information.
- New drug approvals and late-stage trial data necessitate ongoing evaluation of drug utilization.
Purpose of the Study:
- To describe the content and utility of The Formulary Monograph Service.
- To highlight the service's role in supporting P&T Committee decision-making and medication use evaluation (MUE).
Main Methods:
- The service delivers 5-6 detailed monographs on new or late-phase drugs monthly.
- Includes 1-page summary monographs for pharmacy and nursing in-services.
- Provides comprehensive drug utilization evaluation/medication use evaluation (DUE/MUE) reports.
Main Results:
- Subscribers receive accessible online monographs.
- Monographs can be customized to facility-specific needs.
- Selected reviews are published in Hospital Pharmacy.
Conclusions:
- The Formulary Monograph Service offers a valuable resource for healthcare facilities.
- It supports evidence-based formulary management and medication safety initiatives.
Related Concept Videos
01:11Renal Failure: Dose Adjustments
84
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
84
01:20Antiepileptic Drugs: Potassium Channel Activators
173
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
173